GlassScriptPhysician profile
Gilad David Birnbaum
NPI 1982091146
$71,467.97
in general payments reported to CMS, 2019-2025
34 companies · $3,265 in 2025
The $3,265 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,481 · 2020: $4,481 · 2021: $8,278 · 2022: $35K · 2023: $12K · 2024: $2,978 · 2025: $3,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $2,929 · Grant: $1,500 · Consulting Fee: $625 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,366.16 |
| Travel and Lodging | $2,929.36 |
| Grant | $1,500.00 |
| Consulting Fee | $625.00 |
| Education | $128.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25,779.62 | 2021-2025 | Cobalt Dr Mri Surescan, Reveal Linq, Micra |
| Abbott Laboratories | $22,163.63 | 2019-2025 | Aveir, Gallant, Assurity |
| Boston Scientific Corporation | $12,650.98 | 2019-2025 | Ingevity+, Lux-Dx Insertable Cardiac Monitor, Rhythmia Mapping System |
| Biosense Webster, INC. | $5,563.98 | 2021-2025 | Carto 3, Qdot Micro Catheter, Na |
| Medical Device Business Services, INC. | $1,420.73 | 2022 | |
| Impulse Dynamics (USA) INC. | $1,013.57 | 2021-2024 | Optimizer, Optimizer |
| Amgen INC. | $430.89 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $351.91 | 2021-2024 | Opsumit, Uptravi |
| Pfizer INC. | $344.53 | 2019-2025 | |
| Biotronik INC. | $270.54 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $196.59 | 2021-2025 | |
| Philips North America LLC | $146.31 | 2024 | (5153) Azurion 5 M20 Gc |
| Astellas Pharma US INC | $140.72 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $128.50 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $118.43 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $110.79 | 2019-2020 | |
| Novo Nordisk INC | $106.77 | 2022-2025 | Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.84 | 2024-2025 | Lifevest |
| Cvrx, INC. | $57.23 | 2024-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $41.72 | 2022-2023 | |
| Cardiofocus, INC. | $36.71 | 2020 | |
| Merck Sharp & Dohme LLC | $34.65 | 2024 | Verquvo |
| W. L. Gore & Associates, INC. | $32.01 | 2022-2023 | Gore Cardioform Septal Occluder |
| Baxter Healthcare | $28.86 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Cardiva Medical, INC. | $24.94 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Glaxosmithkline, LLC. | $21.81 | 2025 | Shingrix, Arexvy |
| Shockwave Medical, INC | $21.30 | 2022 | |
| Lantheus Medical Imaging, INC. | $20.38 | 2021 | |
| Cordis US Corp. | $19.33 | 2024 | Mynx Venous Vcd |
| Inspire Medical Systems, INC. | $19.30 | 2025 | Inspire |
| Scpharmaceuticals INC. | $17.82 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $16.87 | 2024 | Arcalyst |
| Chiesi USA, INC. | $16.76 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.95 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilad Birnbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.